Lipid-Based Nutrient Supplementation Increases High-Density Lipoprotein (HDL) Cholesterol Efflux Capacity and Is Associated with Changes in the HDL Glycoproteome in Children | ACS Omega
Photorenewable Azobenzene Polymer Brush-Modified Nanoadsorbent for Selective Adsorption of LDL in Serum | ACS Applied Materials & Interfaces
![JCM | Free Full-Text | Hypercholesterolemia Diagnosis, Treatment Patterns, and 12-Month Target Achievement in Clinical Practice in Germany in Patients with Familial Hypercholesterolemia JCM | Free Full-Text | Hypercholesterolemia Diagnosis, Treatment Patterns, and 12-Month Target Achievement in Clinical Practice in Germany in Patients with Familial Hypercholesterolemia](https://www.mdpi.com/jcm/jcm-11-03810/article_deploy/html/images/jcm-11-03810-g001-550.jpg)
JCM | Free Full-Text | Hypercholesterolemia Diagnosis, Treatment Patterns, and 12-Month Target Achievement in Clinical Practice in Germany in Patients with Familial Hypercholesterolemia
![Lipid values in the BAS and FAS and change in lipid values in the FAS. | Download Scientific Diagram Lipid values in the BAS and FAS and change in lipid values in the FAS. | Download Scientific Diagram](https://www.researchgate.net/publication/361720217/figure/tbl2/AS:1175669245517837@1657312799393/Lipid-values-in-the-BAS-and-FAS-and-change-in-lipid-values-in-the-FAS.png)
Lipid values in the BAS and FAS and change in lipid values in the FAS. | Download Scientific Diagram
![Molecules | Free Full-Text | Lunasin Improves the LDL-C Lowering Efficacy of Simvastatin via Inhibiting PCSK9 Expression in Hepatocytes and ApoE−/− Mice Molecules | Free Full-Text | Lunasin Improves the LDL-C Lowering Efficacy of Simvastatin via Inhibiting PCSK9 Expression in Hepatocytes and ApoE−/− Mice](https://pub.mdpi-res.com/molecules/molecules-24-04140/article_deploy/html/images/molecules-24-04140-ag.png?1574978513)
Molecules | Free Full-Text | Lunasin Improves the LDL-C Lowering Efficacy of Simvastatin via Inhibiting PCSK9 Expression in Hepatocytes and ApoE−/− Mice
![PDF) Colesevelam enhances the beneficial effects of brown fat activation on hyperlipidemia and atherosclerosis development PDF) Colesevelam enhances the beneficial effects of brown fat activation on hyperlipidemia and atherosclerosis development](https://i1.rgstatic.net/publication/336346738_Colesevelam_enhances_the_beneficial_effects_of_brown_fat_activation_on_hyperlipidemia_and_atherosclerosis_development/links/5e98828ba6fdcca7891e8020/largepreview.png)
PDF) Colesevelam enhances the beneficial effects of brown fat activation on hyperlipidemia and atherosclerosis development
![Cholestérol LDL (haut, bas) : quel est le taux normal et quand s'inquiéter ? : Femme Actuelle Le MAG Cholestérol LDL (haut, bas) : quel est le taux normal et quand s'inquiéter ? : Femme Actuelle Le MAG](https://fac.img.pmdstatic.net/fit/https.3A.2F.2Fi.2Epmdstatic.2Enet.2Ffac.2F2023.2F02.2F06.2F1ae51922-f773-4a2c-a97d-12dec02f64c0.2Ejpeg/1200x600/quality/80/crop-from/center/cholesterol-ldl-haut-bas-quel-est-le-taux-normal-et-quand-s-inquieter.jpeg)
Cholestérol LDL (haut, bas) : quel est le taux normal et quand s'inquiéter ? : Femme Actuelle Le MAG
![Patient flow. BAS baseline analysis set; FAS full analysis set; CRF... | Download Scientific Diagram Patient flow. BAS baseline analysis set; FAS full analysis set; CRF... | Download Scientific Diagram](https://www.researchgate.net/publication/363637836/figure/fig1/AS:11431281117599207@1675479590009/Patient-flow-BAS-baseline-analysis-set-FAS-full-analysis-set-CRF-case-report-form-FU.png)
Patient flow. BAS baseline analysis set; FAS full analysis set; CRF... | Download Scientific Diagram
Bile Acid Sequestrants for Hypercholesterolemia Treatment Using Sustainable Biopolymers: Recent Advances and Future Perspectives | Molecular Pharmaceutics
![Bile Acid Sequestrants for Hypercholesterolemia Treatment Using Sustainable Biopolymers: Recent Advances and Future Perspectives | Molecular Pharmaceutics Bile Acid Sequestrants for Hypercholesterolemia Treatment Using Sustainable Biopolymers: Recent Advances and Future Perspectives | Molecular Pharmaceutics](https://pubs.acs.org/cms/10.1021/acs.molpharmaceut.2c00007/asset/images/large/mp2c00007_0017.jpeg)
Bile Acid Sequestrants for Hypercholesterolemia Treatment Using Sustainable Biopolymers: Recent Advances and Future Perspectives | Molecular Pharmaceutics
![Elevated cholesterol levels have a poor prognosis in a cholestasis scenario - Nuño‐Lámbarri - 2017 - Journal of Biochemical and Molecular Toxicology - Wiley Online Library Elevated cholesterol levels have a poor prognosis in a cholestasis scenario - Nuño‐Lámbarri - 2017 - Journal of Biochemical and Molecular Toxicology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/08f3e5cf-97c2-4a06-a0a6-7c5be4390ad0/jbt21831-fig-0001-m.jpg)